Skip to content
MedsAcross

Medicine

Tirofiban 5 mg/100 mL injection

Tirofiban · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Tirofiban 5 mg/100 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Do not freeze. Store tirofiban hydrochloride injection at controlled room…

Key facts

Active ingredient (INN)
Tirofiban
Brand
Sold under the generic name
Strength
5 mg/100 mL
Dosage form
Injection
Route
Intravenous
Packs
1 pouch of 100 mL, 1 bag of 100 mL
Manufacturers
EugiaIndiaNexus Pharmaceuticals
Origin register
US FDA, United States
Storage
Do not freeze. Store tirofiban hydrochloride injection at controlled room temperature, 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Protect from light during storage.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
B01AC17 Tirofiban
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 May 2023
Identifiers
RxCUI 1737466, 1737471DailyMed set ID d554acff-22e9-4f28-b826-ee1b91daa2df, 7731e46a-2121-441b-b090-12dcefe240f0NDC 55150-429, 14789-101Application ANDA216379, ANDA213947

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 pouch in 1 carton / 1 bag in 1 pouch / 100 mL in 1 bag55150-429-01EugiaIndia1 May 2023
1 bag in 1 carton / 100 mL in 1 bag14789-101-01Nexus Pharmaceuticals25 September 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 14 May 1998Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Tirofiban 5 mg/100 mL injection.

Compare 1

Other strengths and forms of Tirofiban

Clinical summary

Tirofiban is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). MedsAcross supplies Tirofiban for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Tirofiban

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Tirofiban 5 mg/100 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.